Health Canada is expected to approve Pfizer’s COVID-19 therapeutic today for use in this country, sources told CBC News and Radio-Canada.
Dr. Supriya Sharma, the health regulator’s chief medical adviser, will speak to the media at 11 a.m. ET. CBCNews.ca will carry her remarks live.
Pfizer’s Paxlovid, which is an antiviral prescribed by a doctor and administered in pill form, is designed to help the body fight off the SARS-CoV-2 virus, reduce symptoms from an infection and shorten the period of illness.
The product has been hailed as a pandemic “game changer” by some doctors because it could reduce hospitalizations
